LPL Financial’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,223
| Closed | -$255K | – | 5439 |
|
|
2024
Q4 | $255K | Buy |
+11,223
| New | +$245K | ﹤0.01% | 4656 |
|
|
2024
Q3 | – | Sell |
-46,263
| Closed | -$1.35M | – | 5230 |
|
|
2024
Q2 | $1.35M | Buy |
46,263
+205
| +0.4% | +$6.08K | ﹤0.01% | 2965 |
|
|
2024
Q1 | $1.63M | Buy |
46,058
+16,132
| +54% | +$645K | ﹤0.01% | 2719 |
|
|
2023
Q4 | $1.3M | Buy |
29,926
+2,378
| +9% | +$93.6K | ﹤0.01% | 2812 |
|
|
2023
Q3 | $1.05M | Sell |
27,548
-1,314
| -5% | -$55.3K | ﹤0.01% | 2854 |
|
|
2023
Q2 | $1.19M | Sell |
28,862
-520
| -2% | -$25K | ﹤0.01% | 2706 |
|
|
2023
Q1 | $1.69M | Buy |
29,382
+3,100
| +12% | +$175K | ﹤0.01% | 2291 |
|
|
2022
Q4 | $1.51M | Buy |
26,282
+2,208
| +9% | +$112K | ﹤0.01% | 2305 |
|
|
2022
Q3 | $1.02M | Sell |
24,074
-374
| -2% | -$19.2K | ﹤0.01% | 2529 |
|
|
2022
Q2 | $1.33M | Buy |
24,448
+2,005
| +9% | +$120K | ﹤0.01% | 2340 |
|
|
2022
Q1 | $1.44M | Buy |
22,443
+3,821
| +21% | +$252K | ﹤0.01% | 2320 |
|
|
2021
Q4 | $1.26M | Buy |
18,622
+3,978
| +27% | +$269K | ﹤0.01% | 2456 |
|
|
2021
Q3 | $1.01M | Buy |
14,644
+4,145
| +39% | +$293K | ﹤0.01% | 2602 |
|
|
2021
Q2 | $716K | Buy |
10,499
+570
| +6% | +$40.3K | ﹤0.01% | 2851 |
|
|
2021
Q1 | $686K | Sell |
9,929
-31
| -0.3% | -$2.1K | ﹤0.01% | 2743 |
|
|
2020
Q4 | $647K | Sell |
9,960
-210
| -2% | -$11.3K | ﹤0.01% | 2524 |
|
|
2020
Q3 | $480K | Buy |
10,170
+1,662
| +20% | +$79.1K | ﹤0.01% | 2502 |
|
|
2020
Q2 | $400K | Buy |
8,508
+1,515
| +22% | +$74.5K | ﹤0.01% | 2598 |
|
|
2020
Q1 | $312K | Buy |
6,993
+769
| +12% | +$40.4K | ﹤0.01% | 2474 |
|
|
2019
Q4 | $359K | Buy |
6,224
+268
| +4% | +$16K | ﹤0.01% | 2640 |
|
|
2019
Q3 | $358K | Buy |
5,956
+202
| +4% | +$12K | ﹤0.01% | 2536 |
|
|
2019
Q2 | $319K | Buy |
5,754
+242
| +4% | +$12.5K | ﹤0.01% | 2647 |
|
|
2019
Q1 | $304K | Sell |
5,512
-120
| -2% | -$6.11K | ﹤0.01% | 2625 |
|
|
2018
Q4 | $254K | Sell |
5,632
-42
| -0.7% | -$2.3K | ﹤0.01% | 2599 |
|
|
2018
Q3 | $374K | Sell |
5,674
-1,558
| -22% | -$96.8K | ﹤0.01% | 2472 |
|
|
2018
Q2 | $466K | Buy |
7,232
+392
| +6% | +$24.3K | ﹤0.01% | 2253 |
|
|
2018
Q1 | $376K | Buy |
6,840
+1,523
| +29% | +$79.8K | ﹤0.01% | 2406 |
|
|
2017
Q4 | $260K | Buy |
5,317
+10
| +0.2% | +$489 | ﹤0.01% | 2621 |
|
|
2017
Q3 | $260K | Sell |
5,307
-2,744
| -34% | -$141K | ﹤0.01% | 2478 |
|
|
2017
Q2 | $414K | Buy |
8,051
+2,477
| +44% | +$118K | ﹤0.01% | 2022 |
|
|
2017
Q1 | $234K | Sell |
5,574
-164
| -3% | -$7.01K | ﹤0.01% | 2382 |
|
|
2016
Q4 | $244K | Buy |
+5,738
| New | +$233K | ﹤0.01% | 2330 |
|
Other funds holding IART
RCMNY
LPL Financial's IART Position: Q1 2025 in Review
LPL Financial sold out of Integra LifeSciences (IART) in Q1 2025, closing a stake of 11,223 shares — an estimated $255K sold.
LPL Financial first reported a position in IART in Q4 2016 and held it in 32 quarters. The position peaked at $1.69M in Q1 2023. 219 funds tracked by Wall St. Rank hold IART as of Q1 2025.
- LPL Financial reported no remaining Integra LifeSciences position as of Q1 2025 after selling out during the quarter.
- LPL Financial sold 11,223 Integra LifeSciences shares in Q1 2025, an estimated $255K.
- LPL Financial first reported a position in Integra LifeSciences in Q4 2016 and held it in 32 quarters.
- LPL Financial's Integra LifeSciences position peaked at $1.69M in Q1 2023.
- 219 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2025.
Based on LPL Financial's 13F filing for Q1 2025, filed 7 May 2025.